F&E, Pharmakovigilanz & Regulatory Affairs

F&E, Pharmakovigilanz & Regulatory Affairs

Forschung, Entwicklung, Testung und Einführung neuer Arzneimittel. Der Entwicklungsprozess dauert 8 bis 10 Jahre und besteht aus 4 Phasen.

  • F&E, Pharmakovigilanz & Regulatory Affairs

    Forschung, Entwicklung, Testung und Einführung neuer Arzneimittel. Der Entwicklungsprozess dauert 8 bis 10 Jahre und besteht aus 4 Phasen.
Stellenbezeichnung Sort ascending Standort Datum Req ID
Zurücksetzen
Clinical Operations Intern
Clinical Operations Intern Toronto, CA 12.02.2026 6934
Toronto, CA 12.02.2026 6934
Clinical Program Leader
Clinical Program Leader Europe - Remote, IT 02.02.2026 5902
Europe - Remote, IT 02.02.2026 5902
Clinical Trial Documentation & Records Management Lead
Clinical Trial Documentation & Records Management Lead Parma, IT 15.02.2026 6428
Parma, IT 15.02.2026 6428
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 29.01.2026 5993
PARMA, IT 29.01.2026 5993
Intern, Regulatory Affairs, Global Rare Diseases - Summer 2026
Intern, Regulatory Affairs, Global Rare Diseases - Summer 2026 Cary, NC, US 14.02.2026 6413
Cary, NC, US 14.02.2026 6413
Manager, CMC Regulatory Affairs, Global Rare Diseases
Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 10.02.2026 6592
Europe, IT 10.02.2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 06.02.2026 351
Hamburg, DE 06.02.2026 351
R&D Manufacturing & Technology Transfer Manager
R&D Manufacturing & Technology Transfer Manager Parma, IT 20.01.2026 6501
Parma, IT 20.01.2026 6501
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases UK, GB 14.02.2026 5448
UK, GB 14.02.2026 5448
Senior Director, Clinical Biometrics & Analytics
Senior Director, Clinical Biometrics & Analytics Parma, IT 12.02.2026 6387
Parma, IT 12.02.2026 6387
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 16.02.2026 6111
Europe, IT 16.02.2026 6111
Senior Global Project Manager
Senior Global Project Manager Cary, USA, US 05.02.2026 6561
Cary, USA, US 05.02.2026 6561
Senior Global Project Manager
Senior Global Project Manager Italy, IT 30.01.2026 6546
Italy, IT 30.01.2026 6546
Sr. Director, Clinical Programs, Global Rare Diseases
Sr. Director, Clinical Programs, Global Rare Diseases Boston, MA, US 24.01.2026 6205
Boston, MA, US 24.01.2026 6205
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 22.01.2026 6204
United States, US 22.01.2026 6204